Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
CJC-1295 structure

CJC-1295

Growth Hormone
Phase 2 Research
45%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 100 mcg
Range 100 - 300 mcg
Maintenance 100 mcg 2-3x daily

Pharmacokinetics

Half-Life 30 min
Onset 5 min
Peak 15 min
Duration 2.0 hrs
Bioavailability 95%
Primary Route Subcutaneous

Administration

Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Post-Workout

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 1000 mcg/mL
Stability 21 days refrigerated
Vial Sizes 2, 5 mg

Special Instructions

Best combined with a GHRP like Ipamorelin for synergistic effect. Take on empty stomach.